Latest Breaking News On - Patrick ritschel - Page 1 : vimarsana.com

Atsena Therapeutics Receives Rare Pediatric Disease Designation from FDA for ATSN-101 Gene

DURHAM, N.C., Jan. 16, 2024 (GLOBE NEWSWIRE) Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, today

United statesNorth carolinaPatrick ritschelChristine nichols kaySanford boyeShannon boyeTony plohorosMacula society meetingCarolina research triangleDrug administrationUniversity of floridaRare pediatric diseaseRegenerative medicine advanced therapyBiologics license applicationPriority review voucherPediatric disease

Atsena Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ATSN-101 Gene Therapy for GUCY2D-associated Leber Congenital Amaurosis (LCA1)

Atsena Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ATSN-101 Gene Therapy for GUCY2D-associated Leber Congenital Amaurosis (LCA1)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

North carolinaUnited statesPatrick ritschelSanford boyeShannon boyeTony plohorosUniversity of floridaFoundation fighting blindnessCarolina research triangleDrug administrationRegenerative medicine advanced therapyChief executive officerJason menzoFoundation fightingCentury cures actResearch triangle

Atsena Therapeutics Announces Opening of New Office and

World-class facility supports the company’s growth, and discovery and development of gene therapies for inherited retinal diseases .

North carolinaUnited statesShannon boyeSanford boyeTony plohorosPatrick ritschelUniversity of floridaResearch triangleAlexandria centerCarolina research triangleAdvanced technologiesChief executive officerAtsena therapeutics

Atsena Therapeutics Announces Presentations at ARVO 2022 Annual Meeting and ASGCT 25th Annual Meeting

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

North carolinaUnited statesKaitlyn calabroEva andres mateosLindab coutoTony plohorosPatrick ritschelShannon boyeSanford boyeSanfordl boyeAmerican society of gene cell therapyUniversity of floridaTranslational researchAssociation for researchViral vector development workshopCarolina research triangle

Atsena Therapeutics Unveils XLRS Gene Therapy Program

Subretinal delivery of RS1 using AAV capsid that spreads laterally beyond the injection site overcomes challenges associated with intravitreal delivery .

New jerseyUnited statesNorth carolinaLindab coutoShannon boyeSanford boyeTony plohorosPatrick ritschelUniversity of floridaDrug administrationCarolina research triangleChief executive officerChief scientific officerResearch triangleAtsena therapeutics